Best Online Enclomiphene Clinics 2026: Provider Comparison for Cost, Labs, and Fertility

Executive Summary

Enclomiphene is not a testosterone replacement — it is a selective estrogen receptor modulator (SERM) that stimulates your own pituitary-testicular axis to produce more testosterone. That mechanism is what makes it attractive: you raise testosterone without suppressing the HPT axis, without causing testicular atrophy, and without compromising sperm production. For men with secondary hypogonadism and fertility goals, it is often the clinically superior first-line option over exogenous TRT. The problem is that not all online enclomiphene clinics are built the same way. Some offer deep monitoring with protocol adjustment depth; others have light-touch async models that work for straightforward cases but break down under real-world variation. Choosing the wrong clinic means paying for a program that cannot safely manage your case when something changes at month three.

The short prerequisite that most buying guides skip: enclomiphene only works for secondary hypogonadism. If your LH and FSH are low or low-normal alongside low testosterone — meaning your pituitary is under-driving the axis — enclomiphene can stimulate your testes to produce more testosterone. If your LH and FSH are already elevated (primary hypogonadism), your testes cannot respond to more stimulation and enclomiphene will not work. Before comparing any of these providers, confirm your LH and FSH panel alongside your total testosterone test. If you have not done this yet, read primary vs. secondary hypogonadism to understand which diagnosis applies to you.

This guide covers the best online enclomiphene clinics in 2026: what each one actually prescribes, what the all-in cost looks like, how monitoring depth differs, which clinical profiles each one is designed for, and a five-question scorecard you can use to evaluate any provider before committing. For the clinical decision between enclomiphene and TRT, see enclomiphene vs. TRT. For a side-by-side view of Hims, Maximus, and Roman on this specific question, see does Hims offer TRT. For full provider profiles, use the provider comparison tool.

At-a-Glance Comparison

All-in monthly estimates include medication, prorated lab costs, and standard monitoring. Enclomiphene is only appropriate for secondary hypogonadism — confirm your LH/FSH before enrolling in any program. Updated March 2026.

Who Actually Qualifies for Enclomiphene (Before Comparing Clinics)

Enclomiphene is not a substitute for TRT in all cases of low testosterone — it is specifically effective for secondary hypogonadism, where the problem is insufficient pituitary signaling rather than impaired testicular function. Getting this wrong is the most expensive mistake you can make in this comparison. Buyers searching for best online enclomiphene clinics 2026 usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Before you evaluate any provider, confirm two biomarkers: your total testosterone (to establish that you are genuinely hypogonadal, typically below 300 ng/dL) and your LH and FSH levels. If LH and FSH are low or low-normal — meaning your pituitary is not adequately driving the axis — you are a candidate for enclomiphene. If LH and FSH are already elevated (typically above 8–10 mIU/mL for LH, above 10 mIU/mL for FSH), your testes are not responding to stimulation and enclomiphene will not work. In that case, TRT is the appropriate pathway. The Repros Phase 3 clinical trials showed enclomiphene produced average testosterone increases of 100–200 ng/dL in appropriately selected secondary hypogonadism patients while maintaining sperm count — a profile that distinguishes it clearly from clomiphene and from TRT. For the complete diagnostic framework, see primary vs. secondary hypogonadism and how to read testosterone lab results. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Enrolling in an enclomiphene program without confirming LH/FSH means you may spend three months on a treatment that cannot physiologically work for your diagnosis. Many lower-cost telehealth programs do not require LH/FSH at baseline — they rely on total testosterone alone. This is a monitoring quality signal worth evaluating before you sign up. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Maximus Tribe: Best Dedicated Enclomiphene Program for Secondary Hypogonadism

Maximus is the best-known dedicated enclomiphene provider in the telehealth space and is consistently cited as the top performance-focused platform for men who want testosterone optimization without HPT axis suppression. Buyers searching for best online enclomiphene clinics 2026 usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Maximus offers an enclomiphene-only program and a testosterone + enclomiphene combination protocol (testosterone cream plus enclomiphene to maintain spermatogenesis while on exogenous T). Their at-home lab model — which includes two required testosterone lab draws priced at $72.50 each — drives higher monitoring compliance than programs that rely on patients self-ordering labs. Pricing runs $199/month on a month-to-month basis, dropping to approximately $120/month on an annual plan. Board-certified physicians manage prescriptions and are accessible via 24/7 messaging. Maximus is explicitly optimization-focused, not just normalization-focused, which means they attract men who want to actively manage their hormone profile rather than simply maintain a baseline. For fertility-conscious men specifically, their testosterone + enclomiphene combo protocol is one of the few programs that systematically addresses spermatogenesis alongside testosterone optimization. Maximus is profiled in detail at Hims vs. Roman vs. Maximus TRT comparison. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Maximus's at-home lab model requires active patient participation. If you do not complete required follow-up labs, protocol adjustment quality degrades. At $199/month without annual commitment, total program cost with labs runs approximately $290–$350/month — meaningful for a multi-year protocol. Confirm your state is covered and that your LH/FSH pattern confirms secondary hypogonadism before enrollment. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Hims: Best for Low-Friction Enclomiphene Access with Fertility Preservation

Hims is the highest-volume telehealth platform offering enclomiphene and is the right choice if you want fast onboarding, digital-first management, and a well-branded consumer experience — provided your diagnosis fits their clinical model. Buyers searching for best online enclomiphene clinics 2026 usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Hims added enclomiphene to their testosterone product line specifically as a secondary hypogonadism pathway and fertility-preserving alternative to exogenous TRT. Their process is fast: intake questionnaire, labs, physician review, prescription. Pricing runs approximately $99–$175/month for the enclomiphene program, with labs billed separately. The key clinical constraint that Hims applies — and that you should verify at enrollment — is that they prescribe enclomiphene only for secondary hypogonadism. If your LH/FSH are elevated, their system will not approve you for enclomiphene. Hims also now offers Kyzatrex (oral TRT) for men with primary hypogonadism or those who need exogenous testosterone, so they have a fallback pathway if enclomiphene is not appropriate. For a detailed breakdown of what Hims prescribes vs. what they do not, see does Hims offer TRT. For the Hims vs. Roman vs. Maximus head-to-head, see Hims vs. Roman vs. Maximus TRT comparison. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Hims operates a consumer-volume async model. Protocol adjustment speed may lag specialty platforms, and clinician continuity is not guaranteed. Their monitoring model is lighter than Maximus or Defy Medical. For straightforward secondary hypogonadism cases, this is manageable. For men with complex endocrine history or who need rapid protocol adjustment, it is a relevant trade-off. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Defy Medical and Marek Health: Specialist Models for Complex Enclomiphene Cases

Defy Medical and Marek Health occupy the specialist end of the enclomiphene market — higher cost, deeper monitoring, broader panel coverage, and physician continuity that mass-market telehealth platforms cannot match. Both are appropriate for men whose cases involve complicating factors beyond straightforward secondary hypogonadism. Buyers searching for best online enclomiphene clinics 2026 usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Defy Medical is a physician-led specialty hormone clinic that offers enclomiphene as a stand-alone treatment and as part of combination protocols. Their monitoring model includes full comprehensive panels covering thyroid, SHBG, estradiol, CBC, and metabolic markers alongside testosterone and gonadotropins — not just the testosterone-only snapshots that lower-cost platforms rely on. Monthly cost runs $180–$450 depending on monitoring intensity and medication complexity. They manage complex cases that include prior TRT history, fertility workups, thyroid interactions, and protocol escalations. Marek Health takes a functional medicine approach: higher upfront investment ($450–$1,700 for comprehensive baseline diagnostics) but root-cause framing that maps hormones within metabolic, thyroid, and lifestyle context. Monthly ongoing costs run $150–$300 after the initial diagnostic investment. For men who want to understand the full picture — not just testosterone — Marek Health's approach produces a more complete baseline but requires comfort with higher upfront lab spending. Both platforms are referenced in best online TRT clinics compared 2026. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: The higher cost of specialist platforms is only justified when your case complexity requires it. For straightforward secondary hypogonadism in an otherwise healthy man with clean labs, Maximus or Hims will deliver similar clinical outcomes at significantly lower cost. Defy Medical and Marek Health are worth the premium when: you have a history of treatment failure, complex comorbidities, an extensive prior medication history, or you need rapid escalation management that a high-volume telehealth platform cannot provide. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

The 5-Question Enclomiphene Clinic Scorecard

The gap between a good enclomiphene program and a weak one is almost entirely about process quality — not brand size, not app quality, and not first-month pricing. These five questions expose that gap before you commit. Buyers searching for best online enclomiphene clinics 2026 usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Before enrolling in any enclomiphene clinic, ask each provider these five questions and compare their answers directly: (1) What labs do you require at baseline, and do you require LH and FSH? (2) How often do you require follow-up labs, and who interprets them — a physician or a care coordinator? (3) What is the response time for protocol adjustments? (4) What happens if my testosterone does not respond to enclomiphene — do you have a documented escalation pathway? (5) Who manages my case if my original prescribing physician is unavailable? A clinic that answers these questions with specifics — not generic reassurance — has the process architecture to manage your case over a multi-year treatment horizon. A clinic that deflects or gives vague answers likely relies on standardized templates that may not handle variation well. Run every clinic on your shortlist through this scorecard before making a final decision. Use provider comparison tool for additional side-by-side context. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: Most buyers skip this evaluation step and rely on pricing and reviews alone. The reviews for consumer telehealth platforms tend to be favorable for onboarding experience and negative for clinical depth — which are exactly opposite to what matters for a multi-month hormonal optimization protocol. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

When Enclomiphene Is Not the Right Choice (And What to Do Instead)

Enclomiphene is not appropriate for every man with low testosterone. Understanding when to skip it saves time and prevents clinical dead ends. Buyers searching for best online enclomiphene clinics 2026 usually start with a price question, but the stronger decision model is to evaluate clinical process quality, medication reliability, and support accountability at the same time. In telehealth programs, those three variables determine whether your first protocol can be sustained or has to be rebuilt after 60 to 90 days.

Three situations make enclomiphene a wrong choice: (1) Primary hypogonadism — if your LH and FSH are already elevated, your testes are not responding to normal stimulation. Enclomiphene drives the axis harder but cannot overcome a fundamentally unresponsive Leydig cell population. TRT is the appropriate pathway. (2) Severely deficient testosterone — enclomiphene typically raises testosterone by 100–200 ng/dL over baseline. If you are starting at 180 ng/dL total testosterone and need 600+ ng/dL to resolve symptoms, enclomiphene may not produce adequate response. TRT can target any clinical range. (3) Urgency — if you need fast, predictable testosterone normalization for acute symptom management, exogenous TRT delivers results within 2–4 weeks at consistent levels. Enclomiphene works through a biological amplification pathway that takes 4–8 weeks to show meaningful effect and may not reach your target. For all three situations, the decision framework in enclomiphene vs. TRT walks through the clinical logic in full. If you are concerned about TRT and fertility specifically — and considering enclomiphene to avoid that trade-off — read TRT and fertility for the full picture including hCG protocols that can preserve sperm production on exogenous TRT. A practical way to lower decision regret is to document baseline labs, symptom goals, budget limits, and acceptable side-effect tolerance before enrollment. This turns provider conversations into comparable data points instead of marketing impressions. It also makes follow-up optimization faster because your care team can anchor every change to objective measurements and timeline milestones.

Common failure mode: The biggest clinical risk is spending 3–4 months on enclomiphene before acknowledging that it is not producing adequate response. A well-structured enclomiphene clinic will have a documented escalation path — typically a trial of 90 days with lab-confirmed response evaluation — and will clearly communicate when TRT is the appropriate next step. Avoid that by using explicit check-ins at week 4, week 8, and week 12. If outcomes are under target and side effects are rising, escalate quickly or switch provider pathways instead of waiting for momentum to "self-correct."

Internal Resources to Compare Next

Use these pages to validate assumptions before spending. Cross-checking provider model details with treatment-specific pages is the fastest way to reduce preventable cost drift in month two and month three.

Compare Providers Before You Purchase

Before you enroll in an enclomiphene program, confirm your LH/FSH panel to verify secondary hypogonadism — then use the 5-question scorecard above to evaluate at least three providers before committing.

Disclosure: PeakedLabs may earn a commission from partner links. Editorial scoring and rankings remain independent.

Frequently Asked Questions

Which online clinic is best for enclomiphene in 2026?

The best enclomiphene clinic depends on your clinical profile and priority. Maximus is best for a dedicated optimization-focused program. Hims is best for low-friction onboarding with a clear secondary hypogonadism pathway. Defy Medical or Marek Health are best for complex cases or men who need deep monitoring and physician continuity. All options require confirming secondary hypogonadism (low/low-normal LH and FSH) before enrolling.

Can I get enclomiphene online without a TRT prescription?

Yes — enclomiphene requires its own prescription but it is not TRT (testosterone replacement therapy). It is a SERM that stimulates your own testosterone production. Online platforms like Maximus, Hims, Defy Medical, and Marek Health all prescribe it via telehealth following a baseline lab panel and physician consultation.

How much does enclomiphene cost online per month?

All-in monthly costs depend on the provider and monitoring model. Hims runs approximately $99–$175/month with labs extra. Maximus runs $120–$199/month depending on annual vs. monthly plan, plus $72.50 per lab draw. Defy Medical and Marek Health run $180–$450/month and $150–$300/month respectively, with higher upfront lab investments. Build a 6-month scenario including labs and follow-up for an accurate budget.

Does Maximus offer enclomiphene?

Yes — Maximus offers a dedicated enclomiphene-only program and a testosterone + enclomiphene combination protocol. Their pricing runs $120/month (annual) or $199/month (month-to-month) with two required lab draws at $72.50 each. They are one of the most performance-focused enclomiphene providers in the telehealth space.

Does Hims offer enclomiphene?

Yes — Hims now offers enclomiphene as a secondary hypogonadism pathway alongside Kyzatrex oral TRT. Their enclomiphene program runs approximately $99–$175/month with labs billed separately. Enclomiphene is appropriate only for secondary hypogonadism, which Hims verifies through their intake process.

What labs do I need before starting enclomiphene?

At minimum: total testosterone, LH, and FSH. A complete baseline panel also includes free testosterone, estradiol (E2), SHBG, CBC, and a comprehensive metabolic panel. LH and FSH are the critical determinants of enclomiphene eligibility — low or low-normal LH/FSH confirms secondary hypogonadism. High LH/FSH indicates primary hypogonadism where enclomiphene will not work.

How long does enclomiphene take to work?

Enclomiphene typically requires 4–8 weeks to show meaningful testosterone response at standard dosing (12.5–25 mg daily). Most clinical protocols evaluate efficacy at a 90-day checkpoint with follow-up labs. Unlike exogenous TRT, which raises testosterone within days, enclomiphene works through a biological amplification pathway that takes longer to produce consistent results.

Does enclomiphene preserve fertility?

Yes — enclomiphene preserves and can improve fertility by maintaining HPT axis signaling and FSH-driven spermatogenesis. The Repros Phase 3 trials showed enclomiphene raised testosterone while maintaining sperm parameters in secondary hypogonadism patients. This is the primary reason fertility-conscious men choose enclomiphene over TRT.

What if enclomiphene does not raise my testosterone enough?

Enclomiphene typically raises testosterone by 100–200 ng/dL over baseline. If that is not sufficient to resolve symptoms or reach your target range, TRT is the appropriate escalation. A well-structured enclomiphene clinic will have a documented escalation path with a 90-day response checkpoint and clear criteria for transitioning to TRT.

Can I use enclomiphene if I have primary hypogonadism?

No. Enclomiphene does not work for primary hypogonadism. If your LH and FSH are already elevated — meaning your pituitary is signaling the testes but the testes are not responding — adding more stimulation via enclomiphene will not produce testosterone. TRT is the appropriate pathway for primary hypogonadism.